COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT05673980


Column Value
Trial registration number NCT05673980
Full text link
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

First author
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

Huan Wang, Ms.

Contact
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

wh18324178960@163.com

Registration date
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

2023-01-06

Recruitment status
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

Recruiting

Study design
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

Open label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

Prevention

Inclusion criteria
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

inclusion criteria: willing to participate in the clinical study and sign the informed consent; staff members of peking university third hospital, including the hospital headquarters, capital international airport hospital, north hospital, beijing haidian hospital, peking university third hospital yanqing hospital and peking university third hospital chongli hospital; test negative for covid-19 antigen and have no symptoms related to covid-19.

Exclusion criteria
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

hospital staff with serious underlying diseases; pregnant and lactating women; long-term vegetarians; long-term chronic diarrhea, history of subtotal gastrectomy, biliary obstructive disease and pancreatic disease.

Number of arms
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

2

Funding
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

Peking University Third Hospital

Inclusion age min
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

70

Countries
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

China

Type of patients
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

Healthy volunteers

Severity scale
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

N/A

Total sample size
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

218

primary outcome
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

Change in incidence of laboratory-confirmed (or COVID-19 antibody test) COVID-19 infection

Notes
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

None

Phase
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

Not reported

Arms
Last imported at : Jan. 8, 2023, midnight
Source : ClinicalTrials.gov

[{"arm_notes": "nan", "treatment_id": 1370, "treatment_name": "Vitamin d", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]